The study conducted by Kim S. et al. analyzed 610 CHB patients treated with entecavir or tenofovir disoproxil fumarate, and it was found that patients with ALT normalization within 1 year had a significantly lower cumulative HCC incidence than those with non-normalized ALT (p < 0.001) [17]. This evidence concerns the gene GPT and hepatocellular carcinoma.